Perindopril amlodipine tablet and preparation method thereof
The content uniformity and related substance problems of perindopril amlodipine tablets were solved through dry granulation technology, the process was optimized, and the stability and effect of the drug were improved.
Patent Information
- Application Number
- CN202311380615.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-24
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, the preparation methods of perindopril amlodipine tablets are mostly made of wet granulation, which leads to poor content uniformity and high content of related substances, which affects the stability and effect of the drug.
Using dry granulation technology, grinding, whole granulation and tableting of drugs such as arginine perindopril and amlodipine benzenesulfonate are combined in dry granulator, combining lactose monohydrate, microcrystalline cellulose, and hard Magnesium fatty acid and silica control the content uniformity and dissolution of the finished product.
It effectively reduces the Maillard reaction of raw and auxiliary materials, optimizes the content uniformity and dissolution of the finished product, and improves the stability and effect of the drug.
Smart Images

Figure CN119055599A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medicine preparation and relates to a perindopril amlodipine tablet and a preparation method thereof. Background Art
[0002] Amlodipine besylate is a dihydropyridine calcium antagonist (calcium ion antagonist or slow channel blocker). The contraction of myocardial and smooth muscle depends on the entry of extracellular calcium ions into cells through specific ion channels. Amlodipine besylate selectively inhibits the transmembrane entry of calcium ions into smooth muscle cells and myocardial cells, and its effect on smooth muscle is greater than that on myocardium. Its interaction with calcium channels is determined by the progressive rate of its binding and dissociation with receptor sites, so the pharmacological effect is gradually produced. Since amlodipine besylate is slightly soluble in water and is unstable to light, moisture and heat, the preparation obtained by the general preparation method is prone to degradation under the action of high temperature, high humidity and strong light, thereby affecting the stability of the drug, and is therefore not suitable for wet granulation.
[0003] Perindopril arginine is an angiotensin converting enzyme inhibitor (ACEI). ACEI binds to angiotensin I converting enzyme, thereby inhibiting the generation of angiotensin I, leading to a slowdown in the decomposition of bradykinin, resulting in vasodilation and a decrease in blood pressure. In addition, ACEI can dilate the glomerular arteries, so it can effectively reduce the capillary pressure in the glomerulus, thereby reducing renal hyperperfusion, reducing albumin excretion, thereby reducing urine protein and improving renal function. Since perindopril is soluble in water, it is easy to decompose and produce impurities under water conditions, and it is easy to cyclize and produce impurities under heat conditions, so it is not suitable for wet granulation.
[0004] The combined use of perindopril arginine and amlodipine besylate can play a synergistic role due to their different antihypertensive mechanisms. It not only has a good antihypertensive effect and reduces the dosage of the drugs, but also exerts the advantages of the antihypertensive effect of amlodipine besylate and the renal protection of perindopril arginine. It is a medication method worthy of recommendation.
[0005] However, the preparation methods of perindopril amlodipine tablets in the prior art mostly adopt the wet granulation method, which has the defects of poor content uniformity and high content of related substances. Summary of the invention
[0006] In order to solve the above technical problems, the present invention provides perindopril amlodipine tablets and a preparation method thereof. The present invention adopts dry granulation technology to solve the content uniformity and related substance problems of perindopril arginine and amlodipine besylate after being prepared into finished products.
[0007] The technical solution provided by the present invention is as follows:
[0008] A perindopril amlodipine tablet comprises the following components in parts by mass: 9-11 parts of perindopril arginine, 6.5-7.5 parts of amlodipine besylate, 130-150 parts of lactose monohydrate, 50-60 parts of microcrystalline cellulose, 0.8-1.2 parts of magnesium stearate and 0.4-0.6 parts of silicon dioxide.
[0009] The present invention also provides a method for preparing perindopril amlodipine tablets, the preparation method comprising the following steps:
[0010] Weigh the prescribed amount of perindopril arginine, amlodipine besylate, lactose monohydrate, and microcrystalline cellulose and mix them in a mixer; then grind and mix them using a dry granulator;
[0011] The mixed material is placed in a dry granulator and extruded into flakes, and the flakes are subjected to primary granulation and secondary granulation; the rotation speed of the secondary granulation is lower than that of the primary granulation;
[0012] The granules after granulation are transferred to a hopper mixer, and the prescribed amount of magnesium stearate and silicon dioxide are added for total mixing; after the total mixing, tableting is performed to obtain perindopril amlodipine tablets.
[0013] Furthermore, the mixing time of the raw materials is 20 to 40 minutes, and the mixing frequency is 40 to 50 Hz.
[0014] Furthermore, the rotation speed of the first-stage granulation is 150 rpm, and the rotation speed of the second-stage granulation is 50-150 pm.
[0015] Furthermore, the feeding speed of the mixed material is 160-200 rpm.
[0016] Furthermore, the speed of the roller of the dry granulator is 3 to 6 rpm.
[0017] Furthermore, the aperture screen of the dry granulator is 1.4 to 1.6 mm.
[0018] Furthermore, a circular die with a diameter of 9 mm was used for tableting.
[0019] Furthermore, the rotation speed during tableting is 20 rpm.
[0020] Furthermore, the tableting hardness is controlled to be 50-150N during tableting.
[0021] Beneficial Effects
[0022] The invention reduces the degree of Maillard reaction of raw materials and auxiliary materials in the prescription by comparing different processes of dry granulation and wet granulation, greatly controls the related substances of the finished product; optimizes the process of dry granulation, and controls the content uniformity and dissolution of the finished product. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 It is the spectrum of related substances of wet granulation;
[0024] Figure 2 Related substance profile of the product obtained by dry granulation method;
[0025] Figure 3 It is the intermediate granule after dry granulation. DETAILED DESCRIPTION
[0026] Example 1
[0027] prescription:
[0028]
[0029] Dry granulation process:
[0030] Premixing: Weigh the prescribed amount of perindopril arginine, amlodipine besylate, lactose monohydrate, and microcrystalline cellulose and mix them in a mixer for 30 minutes at a mixing frequency of 45 Hz;
[0031] Grinding: Use a dry granulator for grinding and mixing;
[0032] Dry granulation: The mixed materials are placed in a dry granulator and extruded into flakes, and the flakes are subjected to primary and secondary granulation. Feeding speed: 160-200rpm, roller speed: 3-6rpm, primary granulation speed: 150rpm, secondary granulation speed: 50-150pm, mesh aperture: 1.5mm;
[0033] Total mixing: The granules after granulation are transferred to the hopper mixer, and the prescribed amount of magnesium stearate and silicon dioxide are added for total mixing, and the intermediate granule content is tested (the intermediate content control range is 90%-110%)
[0034] Tablet pressing: Use a 9mm diameter round punch to press the tablets at a speed of 20rpm and control the pressure to form tablets with a hardness of 50-150N.
[0035] Embodiment 2:
[0036] Wet granulation process:
[0037] Premixing: Weigh the prescribed amount of perindopril arginine, amlodipine besylate, lactose monohydrate, and microcrystalline cellulose into a wet mixing granulator, start stirring and chopping for premixing, control the stirring frequency to 30-40 Hz, the chopping frequency to 5-10 Hz, and the mixing time to 10-20 min;
[0038] Wet granulation: Add the prescribed amount of purified water to the premixed material for wet granulation, control the stirring frequency to 30-40 Hz, the chopping frequency to 30-40 Hz, and the granulation time to 20 min;
[0039] Wet granulation: The wet material after wet granulation is wet granulated by a hydraulic lift, the granulation screen is selected with an aperture of 6×6mm, and the granulation frequency is controlled at 5-15Hz;
[0040] Drying: Place the wet granules in a fluidized bed dryer for drying. Set the drying air inlet temperature to 80°C and the drying air outlet temperature to 80°C. Dry until the moisture content is less than 3%.
[0041] Granulation: The dried granules are sized using a 1.0 mm pore size sieve, and the granulation speed is controlled at 15-25 Hz;
[0042] Total mixing: The granules after granulation are transferred to the hopper mixer, and the prescribed amount of magnesium stearate and silicon dioxide are added for total mixing, and the intermediate granule content is tested (the intermediate content control range is 90%-110%)
[0043] Tablet pressing: Use a 9mm diameter round punch to press the tablets at a speed of 20rpm and control the pressure to form tablets with a hardness of 50-150N.
[0044] Comparative Example 1:
[0045] contrast example 1 provides a preparation method of perindopril amlodipine, which differs from Example 1 in that the mixed materials are placed in a dry granulator and extruded into flakes, and the flake materials are subjected to primary granulation. Feeding speed: 160-200rpm, roller speed: 3-6rpm, primary granulation speed: 150rpm, aperture screen: 1.5mm;
[0046] Comparative Example 2:
[0047] contrast example 2 provides a preparation method of perindopril amlodipine, which differs from Comparative Example 1 in that the mixed materials are placed in a dry granulator and extruded into flakes, and the flakes are subjected to primary granulation. Feeding speed: 160-200rpm, roller speed: 3-6rpm, primary granulation speed: 150rpm, mesh aperture: 0.8mm;
[0048] Example results:
[0049] Determination of finished product against the drug product critical quality attributes (COA)
[0050]
[0051]
[0052] Results: From the above results, it can be seen that the wet granulation process introduces moisture, and the amlodipine and lactose monohydrate in the prescription will produce Maillard reaction, which significantly increases the related substances. While the dry granulation process solves the related substances, it makes the powder content uniformity of the granules better.
[0053] Therefore, the dry granulation process can effectively solve the content uniformity of the finished product and the related substances, which is significantly better than the wet granulation process.
Claims
1. A perindopril amlodipine tablet, characterized in that: The perindopril amlodipine tablets comprise the following components in parts by weight: 9-11 parts of perindopril arginine, 6.5-7.5 parts of amlodipine besylate, 130-150 parts of lactose monohydrate, 50-60 parts of microcrystalline cellulose, 0.8-1.2 parts of magnesium stearate, and 0.4-0.6 parts of silicon dioxide.
2. The method for preparing perindopril amlodipine tablets according to claim 1, characterized in that: The preparation method comprises the following steps: Weigh the prescribed amount of perindopril arginine, amlodipine besylate, lactose monohydrate, and microcrystalline cellulose and mix them in a mixer; then grind and mix them using a dry granulator; The mixed material is placed in a dry granulator and extruded into flakes, and the flakes are subjected to primary granulation and secondary granulation; the rotation speed of the secondary granulation is lower than that of the primary granulation; The granules after granulation are transferred to a hopper mixer, and the prescribed amount of magnesium stearate and silicon dioxide are added for total mixing; after the total mixing, tableting is performed to obtain perindopril amlodipine tablets.
3. The method for preparing the perindopril amlodipine tablets according to claim 2, characterized in that: The mixing time of the raw materials is 20 to 40 minutes, and the mixing frequency is 40 to 50 Hz.
4. The method for preparing the perindopril amlodipine tablets according to claim 2, characterized in that: The rotation speed of the first-stage granulation is 150rpm, and the rotation speed of the second-stage granulation is 50-150pm.
5. The method for preparing the perindopril amlodipine tablets according to claim 2, characterized in that: The feeding speed of the mixed material is 160-200rpm.
6. The method for preparing perindopril amlodipine tablets according to claim 2, characterized in that: The speed of the roller of the dry granulator is 3-6 rpm.
7. The method for preparing perindopril amlodipine tablets according to claim 2, characterized in that: The aperture screen of the dry granulator is 1.4-1.6 mm.
8. The method for preparing perindopril amlodipine tablets according to claim 2, characterized in that: The tablets are pressed using a 9mm diameter round die.
9. The method for preparing perindopril amlodipine tablets according to claim 2, characterized in that: The rotation speed during tableting was 20 rpm.
10. The method for preparing perindopril amlodipine tablets according to claim 2, characterized in that: When tableting, control the tableting hardness to 50-150N.
